Core Insights - Guorui Life has signed a share transfer agreement to acquire 78.2898% of Chunyu Doctor for a total price of 269 million RMB, becoming its controlling shareholder and officially entering the digital healthcare sector [1][3] - Chunyu Doctor is one of the early internet healthcare service providers in China, with a service network covering over 300 cities and cumulative user services exceeding 400 million, offering a comprehensive service system that includes online consultation, AI diagnosis, offline treatment, and health management [1][3] Strategic Acquisition - The strategic acquisition by Guorui Life is based on a deep insight into the golden track of digital healthcare, seizing opportunities from policy promotion, market evolution, and model restructuring in the healthcare industry [3] - Chunyu Doctor's mature industrial system, scarce medical resources, and validated business closed loop serve as the core support for Guorui Life's strategic transformation, marking the company's formal entry into the digital healthcare space and its move towards becoming an "industry value co-creator" [3] Market Potential - The layout in the high-growth digital healthcare sector will open up vast market space and greater valuation imagination for Guorui Life [3] - The stable business growth, clear technological medical attributes, and predictable profit prospects brought by Chunyu Doctor will reshape the overall competitiveness and valuation logic of Guorui Life, providing strong new momentum and creating long-term returns for all shareholders [3]
国锐生活战略性收购春雨医生 抢占数字医疗“黄金赛道”入口